Kurome Therapeutics
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
1
Funding Rounds
$15.0m
Money raised
Overview
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Ri** | - | - | - |
| Ma**** Bh****** | - | - | - |
| Ab*** Go**** | - | - | - |
| Sh*** Ma***** | - | - | - |
| Da**** He**** | - | - | - |
Funding series
Funding Series Analysis
The company Kurome Therapeutics has raised a total of $15m in funding over 1 rounds.
Key Insights:
- Kurome Therapeutics Series A round, June 2021: $15m
Kurome Therapeutics Series A round, June 2021
$15m
Industries
Kurome Therapeutics is active in the following industries: